New preclinical research maps tau spread in Alzheimer’s

JHU team demystifies 'one-two punch' that causes Alzheimer’s disease

Approved HIV drug could ward off Alzheimer’s disease

NEA leads $44M round to get Stanford neurodegenerative spinout Annexon into the clinic

Axon’s Alzheimer’s vaccine hits Phase II as it seeks to prove efficacy

Better understanding of enzymes to help find new cancer, Alzheimer’s drugs

GlaxoSmithKline, Sanford Burnham launch neuroscience hub

Solo again, Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio